CNS-Sparing Histamine H3 Receptor Antagonist as a Candidate to Prevent the Diabetes-Associated Gastrointestinal Symptoms (2022)

First Author: Rosa A
Attributed to:  Realising Unmet Potential in Translational Medical Science at Durham funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/biom12020184

PubMed Identifier: 35204685

Publication URI: http://europepmc.org/abstract/MED/35204685

Type: Journal Article/Review

Parent Publication: Biomolecules

Issue: 2

ISSN: 2218-273X